Familial encephalopathy with neuroserpin inclusion bodies

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 1901-1913

  Davis, Richard L ^a   Holohan, Peter D ^a   Shrimpton, Antony E ^a   Tatum, Arthur H ^a   Daucher, John ^a   Collins, George H ^a   Todd, Robert ^a   Bradshaw, Charles ^a   Kent, Paul ^a   Feiglin, David ^a   Rosenbaum, Arthur ^a   Yerby, Mark S ^b   Shaw, Cheng Mei ^c   Lacbawan, Felicitas ^d   Lawrence, Daniel A ^e  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE INHIBITOR;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN CORTEX; BRAIN DISEASE; CELL INCLUSION; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; FAMILIAL DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIGENE FAMILY; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

EID: 0032794402     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65510-1     Document Type: Article

References (52)

1. Hardy J, Gwinn-Hardy K: Genetic classification of primary neurodegenerative disease. Science 1998, 282:1075-1079
2. Price DL, Sisodia SS, Borchelt DR: Genetic neurodegenerative disease: the human illness and transgenic models. Science 1998, 282:1079-1083
3. Muller U, Graeber, MB: Neurogenetic diseases: molecular diagnosis and therapeutic approaches. J Mol Med 1996, 74:71-84
4. Giannakopoulos P, Hof PR, Savioz A, Guimon J, Antonarakis SE, Bouras C: Early-onset dementias: clinical, neuropathological and genetic characteristics. Acta Neuropathol 1996, 91:451-465
5. Hart MN: Contributions of autopsy to modern neurologic science. The Autopsy: Medical Practice and Public Policy. Edited by RB Hill, RE Anderson. Boston, Butterworths, 1988, pp 91-105
6. Schochet SS: Neuronal inclusions. The Structure and Function of Nervous Tissue, vol IV. Edited by GH Bourne. New York, London, Academic Press, 1972, pp 129-177
7. Leigh PN, Probst A, Dale GE, Power DP, Brion JP, Dodson A, Anderton BH: New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol 1989, 79:61-72
8. Cooper PN, Jackson M, Lennox G, Lowe J, Mann DMA: Tau, ubiquitin, and α B-crystallin immunohistochemistry define the principal causes of degenerative fronto temporal dementia: Arch Neurol 1995, 52:1011-1015
9. Davis RL, Daucher JW, Welker DM, Barcza MA, Collins GH: A familial dementia with unusual neuronal inclusions: J Neuropathol Exp Neurol 1996, 55:636 (abstr.)
10. Bulmer D: Dimedone as an aldehyde blocking reagent to facilitate the histochemical demonstration of glycogen. Stain Technol 1959, 34: 95-98
11. Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith EP, Barthlow R, Cherry S, Sandkvist M, Lawrence DA: Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons: implications for the regulation of motor learning and neuronal survival. J Biol Chem 1997, 272:33062-33067
12. Shermann PM, Lawrence DA, Yang AY, Vandenberg ET, Paielli P, Olson ST, Shore JD, Ginsburg D: Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center. J Biol Chem 1992, 267:7588-7595
13. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB: Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989, 52:1236-1247
14. Fukuda T, Tanaka J, Watabe K, Numoto RT, Minamitani M: Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease. Acta Pathol Jpn 1993, 43:545-551
15. Spillantini MG, Schmidt ML, Lee VML, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840
16. Schrimpf SP, Bleiker AJ, Brecevic L, Kozlov SV, Berger P, Osterwalder T, Krueger SR, Schinzel A, Sonderegger P: Human neuroserpin (PI12): cDNA cloning and chromosomal localization to 3q26. Genomics 1997, 40:55-62
17. Yerby MS, Shaw C-M, Watson JMD: Progressive dementia and epilepsy in a young adult: unusual intraneuronal inclusions. Neurology 1986, 36:68-71
18. Cervós-Navarro J, Urich H: Metabolic and Degenerative Diseases of the Central Nervous System: Pathology, Biochemistry, and Genetics. San Diego, Academic Press, 1995
19. Greenfield JG, Bosanquet FD: The brain-stem lesions in Parkinsonism. J Neurol Neurosurg Psychiatry 1953, 16:213-226
20. Delacourte A, Robitalle YU, Sergeant N, Buee L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D: Specific pathological tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996, 55:159-168
21. Averback P: Dense microspheres in normal human brain. Acta Neuropathol 1983, 61:148-152
22. Averback P, Morse D, Ghanbari H: Bursting dense microspheres (spherons) in Alzheimer's disease. J Alzheimer's Dis 1998, 1:1-34
23. Yokoi S, Austin T, Witmer F, Sakai M: Studies in myoclonus epilepsy (Lafora body form). 1. Isolation and preliminary characterization of Lafora bodies in two cases. Arch Neurol 1968, 19:15-33
24. Saka M, Austin J, Witmer F, Trueb L: Studies of corpora amylaceal. 1. Isolation and preliminary characterization by chemical and histochemical techniques. Arch Neurol 1969, 21:526-544
25. Sakai M, Austin J, Witmer F, Trueb L: Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology 1970, 20: 160-176
26. Collins GH, Cowden RR, Nevis AH: Myoclonus epilepsy with Lafora bodies an ultrastructural and cytochemical study. Arch Pathol 1968, 86:239-254
27. Schochet SS, McCormick WF, Zellweger H: Type IV glycogenosis (amylopectinosis): light and electron microscopic observations. Arch Pathol 1970, 90:354-363
28. Robitaille Y, Carpenter S, Karpati G, DiMauro S: A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal aging. Brain 1980, 103:315-336
29. Cavanagh JB: Corpora-amylacea and the family of polyglucosan diseases. Brain Res Rev 1999, 29:265-295
30. Berkovic SF, Carpenter S, Andermann F: Atypical inclusion body progressive myoclonus epilepsy: a fifth case? Neurology 1986, 36: 1275-1276
31. Berkovic SF, Andermann F, Carpenter S, Wolfe LS: Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med 1986, 315:296-305
32. Dastur DK, Singhal BS, Gootz M, Seitelberger F: Atypical inclusion bodies with myoclonic epilepsy. Acta Neuropathol 1966, 7:16-25
33. Bergener M, Gerhard L: Myoklonuskorperkrankheit und myoklonusepilepsie. Nervenarzt 1970, 41:166-173
34. Ota T, Hisatomi Y, Kashiwamura K, Otsu K, Nakamura Y, Takamatsu S, Mehraein P: Histochemistry and ultrastructure of atypical myoclonus body (type II). Acta Neuropathol 1974, 28:45-54
35. Dolman C: Atypical myoclonus body epilepsy (adult variant). Acta Neuropathol 1975, 31:201-206
36. Potempa J, Korzus E, Travis J: The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994, 269:15957-15960
37. Whisstock J, Skinner R, Lesk PM: An atlas of serpin conformations. Trends Biochem Sci 1998, 23:63-67
38. Carrell RW, Lomas DA: Conformational disease. Lancet 1997, 350: 134-138
39. Stein PE, Carrell RW: What do dysfunctional serpins tell us about molecular mobility and disease. Nat Struct Biol 1995, 2:96-113
40. Carrell RW, Lomas DA, Sidhar S, Foreman R: Alpha1-antitrypsin deficiency: a conformational disease. Chest 1996, 110:243S-247S
41. 1-antitrypsin. Nat Struct Biol 1996, 3:676-681
42. 1-antitrypsin. Nat Struct Biol 1996, 3:910-911
43. Gordon HW, Dixon J, Rogers JC, Mittman C, Lieberman J: Alpha A1-antitrypsin (A1AT) accumulation n livers of emphysematous patients with A1AT deficiency: Hum Pathol 1972, 3:361-370
44. Davis RL, Shrimpton AE, Holohan PD, Bradshaw C, Feiglin D, Collins GH, Sonderegger P, Kirter J, Becker LM, Lacbawan F, Krasnewich D, Muenke M, Lawrence DA, Yerby MS, Shaw CM, Gooptu B, Elliot P, Finch JT, Carrell RW, Lomas DA: Familial dementia caused by polymerization of mutant neuroserpin. Nature 1999, 401:376-379
45. Osterwalder T, Cinelli P, Baici A, Pennella A, Krueger SR, Schrimpf SP, Meins M, Sorderegger P: The axonally secreted serine protease inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin. J Biol Chem 1998, 273:2312-2321
46. Smirnova IV, Ho GJ, Fenton II JW, Festoff BW: Extravascular proteolysis and the nervous system: serine protease/serpin balance. Semin Thromb Hemost 1994, 20:426-432
47. Strickland G, Gualandris A, Rogove AD, Tsirka SE: Extracellular proteases in neuronal function and degeneration. Cold Spring Harbor Symp Quant Biol 1996, 61:739-745
48. Turgecn VL, Houenou LJ: The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res Rev 1997, 25:85-95
49. Kakizuka A: Protein precipitation: a common etiology in neurodegenerative disorders? Trends Genet 1998, 14:396-402
50. Goedert M: Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and α-synucleinopathies. Phil Trans R Soc London Ser B 1999, 354:1101-1118
51. Carrell RW, Gooptu B: Conformational changes and disease-serpins, prions and Alzheimer's. Curr Opin Struct Biol 1998, 8:799-809
52. Esiri MM, Oppenheimer DR: Diagnostic Neuropathology. London, Blackwell Scientific, 1989, pp 12-40